SCHEMBL8091423

SCHEMBL8091423

CCCS(=O)(=O)NC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
CA12 O43570 4/20 0.50
CA1 P00915 4/20 0.50
CA9 Q16790 4/20 0.50
CA2 P00918 3/20 0.50
CNR1 P21554 2/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HTT P42858 2/20 0.49
MAPT P10636 1/20 0.49
NLRP1 Q9C000 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
CA4 P22748 1/20 0.47
CA7 P43166 1/20 0.47
GAA P10253 1/20 0.47
RECQL P46063 1/20 0.46
LMNA P02545 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083314 0.91 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8091363 0.90 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8091373 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8091245 0.84 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8091389 0.84 EPHX1 (0.58) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8097633 0.80 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8083371 0.79 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL11221363 0.78 ALDH1A1 (0.61) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8091307 0.78 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8097740 0.78 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed